Mezzion Pharma Co.Ltd (140410) — Capital Reinvestment Ratio

Latest as of September 2023: 1.15x

Mezzion Pharma Co.Ltd (140410) has a Capital Reinvestment Ratio of 1.15x as of September 2023, meaning it reinvests 1% of its operating cash flow (₩4.73 Billion) in capital expenditures (₩5.46 Billion). Check tangible net worth ratio of Mezzion Pharma Co.Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.15x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.73 Billion
KRW

Capital Expenditures

₩5.46 Billion
KRW

Data as of

Sep 2023
Most recent filing

Mezzion Pharma Co.Ltd Capital Reinvestment Ratio (2012–2015)

This chart tracks Mezzion Pharma Co.Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Mezzion Pharma Co.Ltd (140410) cash flow conversion.

Annual Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd (2012–2015)

Year-by-year Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd from 2012 to 2015. See Mezzion Pharma Co.Ltd (140410) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2015 0.32x ₩1.77 Billion ₩564.10 Million ▲ +77.0%
2012 0.18x ₩3.14 Billion ₩564.10 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow